In a groundbreaking move to expand its rare disease portfolio, Biogen, a leading biotechnology company, announced its acquisition of Reata…
Trending
- Four Things Jane Austen Adaptations Often Get Wrong
- Harry Potter play producer says cost of living made two-part show ‘impossible’
- The TikTok Army Fighting Online Hate With Kindness
- Trump Discloses Millions in Stock Trades Involving Major Tech and AI Firms
- AI Leaders Urge UN Cooperation as US Rejects New Global Governance
- Bentley has unveiled its first fully electric car after investing £350m to upgrade its factory in Cheshire.
- The Rise of ‘Dopamine Sites’ That Let You Shop Without Spending
- How Solar Power Is Changing Texas Farms
© 2026 All right Reserved By Biznob.